Search

Filters
Clear All
  • 18
  • 51
  • 642

Phase

  • 14
  • 16
  • 59
  • 8
  • 81
  • 5
  • 519
  • 631
  • 285
  • 698
  • 13

Found 711 in-health trials

A listing of in-health medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

J
Jennifer King
18 years - 100 years
All genders
This study investigates the effects of adding an investigational medication to a standard treatment for patients with high-risk renal cell carcinoma (RCC). RCC is a type of kidney cancer. The purpose of this study is to see if the investigational medication, when combined with the standard treatment, works better than …
M
Myda Khalid
10 years or above
All genders
Phase 2
Interventional
This study investigates the safety and effects of an investigational medication in people with autoimmune kidney diseases. These conditions include IgA Nephropathy (IgAN), Primary Membranous Nephropathy (pMN), and Minimal Change Disease/Focal Segmental Glomerulosclerosis (MCD/FSGS). Autoimmune kidney diseases occur when the body's defense system attacks the kidneys, causing damage. This study …
N
Nicole Fowler
65 years - 100 years
Accepts healthy volunteer
All genders
This study investigates the use of a Passive Digital Marker (PDM) to identify people at risk of Mild Cognitive Impairment (MCI) and Alzheimer's Disease and Related Dementias (ADRD). The PDM is a tool that uses electronic medical records to find patients who might be at risk. Patients identified by the …
S
Sandeep Batra, MD
366 days - 42 years
All genders
Phase 3
This study investigates treatments for a type of blood cancer called Philadelphia chromosome-positive or ABL-class Philadelphia chromosome-like B-cell acute lymphoblastic leukemia (B-ALL). B-ALL is a cancer of the white blood cells. The study looks at the effects of combining blinatumomab, a special antibody that helps the immune system fight cancer, …
E
Eric Orman
18 years - 100 years
All genders
Phase 2
Interventional
This study investigates the effects of an investigational medication on hereditary hemochromatosis, a condition where the body absorbs too much iron from food, leading to excess iron storage in organs. The purpose of this study is to evaluate how the investigational medication affects liver iron concentration (LIC) in adults with …
M
Michael A. Bushey
18 years - 75 years
All genders
Phase 2
Interventional
This study investigates the effects of an investigational medication as an additional treatment for people with opioid use disorder (OUD) who are in early recovery. Opioid use disorder is a condition where individuals have a strong desire to use opioids, even when it causes problems in their life. The study …
R
Rachael Schulte
15 years - 40 years
All genders
This study investigates whether adding levocarnitine to chemotherapy regimens can reduce liver problems, specifically conjugated hyperbilirubinemia, in adolescents and young adults with Acute Lymphoblastic Leukemia (ALL). Conjugated hyperbilirubinemia is a condition where there is too much bilirubin, a substance made during the breakdown of red blood cells, in the blood. …
T
Tarah Ballinger, MD
18 years - 100 years
Female
This study investigates how genetic ancestry affects the completion of treatment in patients diagnosed with breast cancer. Breast cancer is a disease where cells in the breast grow out of control. This study involves newly diagnosed women with stages I-III breast cancer who self-report as Black or White.Participants will provide …
A
Anthony Ross
180 days - 22 years
All genders
Phase 2
Interventional
This study investigates an investigational medication for treating Langerhans cell histiocytosis (LCH), a disease where the body makes too many immature Langerhans cells, a type of white blood cell. These cells can build up and form tumors in organs like bones, skin, and lungs, causing damage. The purpose of the …
R
Rachael Schulte
2 years or above
All genders
Phase 2
Interventional
This study investigates a treatment for PIK3CA Related Overgrowth Spectrum (PROS), a condition caused by a mutation in the PIK3CA gene that leads to abnormal growths in the body. The purpose of this study is to evaluate the safety and effectiveness of an investigational medication targeting these mutations.Participants in this …
521 - 530 of 711